Get the Stockscreener App
8.05
0.98%
-0.08
After Hours:
8.01
-0.04
-0.50%
Pavmed Inc stock is traded at $8.05, with a volume of 4,035.
It is down -0.98% in the last 24 hours and down -18.27% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$8.13
Open:
$8.1872
24h Volume:
4,035
Relative Volume:
0.06
Market Cap:
$58.55M
Revenue:
$71,000
Net Income/Loss:
$-2.47M
P/E Ratio:
-0.2446
EPS:
-32.9143
Net Cash Flow:
$-5.24M
1W Performance:
-9.96%
1M Performance:
-18.27%
6M Performance:
-23.83%
1Y Performance:
-65.15%
1-Day Range:
$8.005
$8.20
1-Week Range:
$8.005
$8.92
52-Week Range:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
8.05 | 59.13M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed Inc (FRA:1P5) Stock Earnings Transcripts - GuruFocus
PAVmed Inc (FRA:1P5) Stock Price & 30 Year Financial Data - GuruFocus
PAVmed Inc (FRA:1P5) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
PAVmed (PAVM) 2026 proxy: ESPP share increase, director elections and auditor vote - Stock Titan
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
[ARS] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics to Hold First Quarter 2026 Business Update Con - GuruFocus
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
[EFFECT] PAVmed Inc. SEC Filing - Stock Titan
SEC Form DEFA14A filed by PAVmed Inc. - Quantisnow
PAVmed Inc. (NASDAQ: PAVM) registers 9.23M shares from Series D conversion - Stock Titan
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed (PAVM) price target decreased by 84.60% to 41.31 - MSN
PAVmed Inc (STU:1P5) Stock PDF (Updated: 2026/04/28) - GuruFocus
Debt to equity ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Pretax income of PAVmed, Inc. – FWB:1P5 - TradingView
Free cash flow of PAVmed, Inc. – FWB:1P5 - TradingView
Return on invested capital % of PAVmed, Inc. – FWB:1P5 - TradingView
Taxes of PAVmed, Inc. – FWB:1P5 - TradingView
Debt to assets ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Total equity of PAVmed, Inc. – FWB:1P5 - TradingView
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Q2 2025 Earnings Preview - MSN
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset - Yahoo Finance
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
PAVmed (PAVM) price target increased by 2,900.00% to 321.30 - MSN
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Latest PAVM NewsPAVmed Collaborates with Canon on DisappEAR... - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com India
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Backed by a $15M investor, Lucid closes $18M share sale - Stock Titan
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - Financial Times
A $15M anchor investor backs Lucid’s 18M-share stock sale - Stock Titan
PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading.Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh
PAVmed (NASDAQ: PAVM) registers 9.23M common shares; $30M potential from warrants - Stock Titan
PAVmed IncFiles Prospectus For Potential Offer And Sale Of 9.23 Million Common Shares By Selling StockholdersSEC Filing - TradingView
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
PAVmed Inc. Series Z Warrant (PAVMZ) - Minichart
PAVmed (PAVM) Stock Resistance Rejection (+0.11%) 2026-04-18Sentiment Analysis - Xã Vĩnh Công
Victoria Tou Ho Lee Net Worth (2026) - GuruFocus
Dana Carrera, Tasso Partners disclose 15.3% stake in PAVmed (NASDAQ: PAVM) - Stock Titan
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):